These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26191222)

  • 1. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
    Zhao P; Lu Y; Liu L
    Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
    Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
    World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.
    Inada R; Sekine S; Taniguchi H; Tsuda H; Katai H; Fujiwara T; Kushima R
    World J Gastroenterol; 2015 Feb; 21(7):2159-68. PubMed ID: 25717252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
    Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D
    Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An abnormally high expression of ISL-1 represents a potential prognostic factor in gastric cancer.
    Guo C; Wang W; Shi Q; Chen P; Zhou C
    Hum Pathol; 2015 Sep; 46(9):1282-9. PubMed ID: 26142548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
    Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
    Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
    J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.
    Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L
    Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
    Hu X; Huang Z; Liao Z; He C; Fang X
    Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
    J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma.
    Wang J; Shen H; Fu G; Zhao D; Wang W
    Oncotarget; 2017 Feb; 8(6):9442-9450. PubMed ID: 28038462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
    Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
    Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Various ARID1A expression patterns and their clinical significance in gastric cancers.
    Kim YB; Ham IH; Hur H; Lee D
    Hum Pathol; 2016 Mar; 49():61-70. PubMed ID: 26826411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients.
    Jiang YX; Li PA; Yang SW; Hao YX; Yu PW
    Int J Clin Exp Pathol; 2015; 8(6):7002-8. PubMed ID: 26261590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas.
    Yi S; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S
    Pathol Res Pract; 2014 Jun; 210(6):363-8. PubMed ID: 24636838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
    Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
    World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.